Latest Listings And Ipos News

Bindi Metals Limited’s BIMO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Atomic Eagle Limited announces Phil Hoskins as new CEO following Daniel Major's unexpected non-start, spotlighting the Muntanga Uranium Project's substantial resource base.

Aumake Limited has raised $1.5 million through a share placement to strengthen inventory and expand its footprint in China, signaling renewed growth ambitions under a refreshed board.

Pantera Minerals has launched trading on the OTCQB Venture Market under ticker PTMLF, broadening its reach to U.S. investors and advancing its critical minerals exploration in Arkansas. This move complements its ASX listing and positions the company at the forefront of America’s push for secure domestic supply chains.

Brazilian Rare Earths Limited’s scoping study confirms the Amargosa Bauxite-Gallium Project as a large-scale, capital-efficient direct-ship bauxite operation with robust economic returns and strategic market positioning.

Fisher & Paykel Healthcare has updated its dividend announcement to include the Australian Dollar equivalent, providing clearer insight for investors ahead of the mid-December payment.

Rand Mining has released a replacement exploration report for the East Kundana Joint Venture, highlighting new JORC disclosures and promising high-grade gold assay results from the Ambition prospect.

Progress 2020-1 Trust has completed the redemption of its A$920 million Class A Floating Rate Notes, leading to their suspension and removal from the ASX Official List.

Locate Technologies secures court approval to transition its holding company to a newly listed New Zealand entity, marking a significant restructuring and ASX delisting.

Tribune Resources has replaced its initial FY2026 Q1 EKJV exploration report with a more detailed version, revealing promising high-grade gold assay results and enhanced compliance disclosures.

Way2Vat Limited’s shareholders have overwhelmingly approved a suite of resolutions at the December 2025 Extraordinary General Meeting, including share placements, executive performance options, and a share consolidation.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.